Contact Us. 1-800-456-2255 Monday to Friday 8:30am to 8:00pm (ET)
"I feel completely comfortable with my decision to take TYSABRI, and I encourage people to talk with their doctor about their treatment."
– Heidi, TYSABRI patient
"I started doing more research on TYSABRI and what stood out to me was the ability to reduce the relapse rate and I decided I would go with TYSABRI."
– Craig, TYSABRI patient
"I would definitely recommend TYSABRI to others who may be experiencing disease activity on another therapy. It's definitely worth a conversation with your doctor and your family."
– Joy, TYSABRI patient
 
Learn why people have chosen TYSABRI
for their relapsing MS treatment.
 
 
<1 2 3 >
 

For adults with relapsing forms of multiple sclerosis (MS) to slow worsening disability and reduce number of flare-ups. Since TYSABRI increases the risk of PML, a rare brain infection that usually causes death or severe disability, it's generally recommended for patients unable to tolerate or respond well to another therapy. See TYSABRI Risk Information.

Know More About TYSABRI

Sign up to receive the latest information on
TYSABRI and relapsing multiple sclerosis
treatments.

Register now

Treating Your Relapsing MS

Tools and resources for living with MS

 
  • Learn about our peer-to-peer teleconferences and any live events in your area.
 
Important Safety Information

Please see full Prescribing Information (PDF) , including Boxed Warning and
Patient Medication Guide (PDF) .


The site you are about to visit is maintained by a third party who is solely responsible for its contents. Biogen Idec provides this link as a service to website visitors. Biogen Idec is not responsible for the content or privacy practices of any third-party websites. We encourage you to read the privacy policy of every website you visit.

Click Cancel to return or OK to continue.

  

You are about to leave this site.

Click Cancel to return or OK to continue.

  

Blank Overlay Used To Show Alert Messages Automatically

Submission Is In Progress
One Moment Please.